Local Treatment of Desmoid Tumors: An Update

Abstract

Desmoid tumors (DTs) are rare fibroblastic proliferations, characterized by infiltrative growth and a propensity for local recurrence. Traditional strategies such as surgery, radiotherapy, and chemotherapy are the mainstays of treatment, each with its limitations and associated risks. The trend in DT management leans toward a “wait-and-see” strategy, emphasizing active surveillance supported by continuous MRI monitoring. This approach acknowledges the unpredictable nature of the disease, and a multidisciplinary management of DT requires a nuanced approach, integrating traditional therapies with emerging interventional techniques. This review highlights the emerging role of minimally invasive interventional radiological technologies and discusses interventional radiology techniques, including chemical, radiofrequency, microwave, cryoablation, and high-intensity focused ultrasound ablations as well as transarterial embolization.

Keywords

desmoid tumor - radiofrequency ablation - microwave ablation - transarterial chemoembolization - interventional radiology

Publication History

Article published online:
10 July 2024

• References

• 1 Fletcher CDM, Bridge JA, Hogendoorn P, Mertens F. WHO Classification of Tumors of Soft Tissue and Bone (IARC WHO Classification of Tumors). 4th ed.. Lyon: IARC Press; 2013
• 2 Penel N, Coindre JM, Bonvalot S. et al. Management of desmoid tumours: a nationwide survey of labelled reference centre networks in France. Eur J Cancer 2016; 58: 90-96
• 3 Kasper B, Ströbel P, Hohenberger P. Desmoid tumors: clinical features and treatment options for advanced disease. Oncologist 2011; 16 (05) 682-693
• 4 Le Guellec S, Soubeyran I, Rochaix P. et al. CTNNB1 mutation analysis is a useful tool for the diagnosis of desmoid tumors: a study of 260 desmoid tumors and 191 potential morphologic mimics. Mod Pathol 2012; 25 (12) 1551-1558
• 5 Yan YY, Walsh JP, Munk PL. et al. A single-center 10-year retrospective analysis of cryoablation for the management of desmoid tumors. J Vasc Interv Radiol 2021; 32 (09) 1277-1287
• 6 Desmoid Tumor Working Group. The management of desmoid tumours: a joint global consensus-based guideline approach for adult and paediatric patients. Eur J Cancer 2020; 127: 96-107
• 7 Nieuwenhuis MH, Casparie M, Mathus-Vliegen LMH, Dekkers OM, Hogendoorn PCW, Vasen HFA. A nation-wide study comparing sporadic and familial adenomatous polyposis-related desmoid-type fibromatoses. Int J Cancer 2011; 129 (01) 256-261
• 8 Bektas M, Bell T, Khan S. et al. Desmoid tumors: a comprehensive review. Adv Ther 2023; 40 (09) 3697-3722
• 9 Robbin MR, Murphey MD, Temple HT, Kransdorf MJ, Choi JJ. Imaging of musculoskeletal fibromatosis. Radiographics 2001; 21 (03) 585-600
• 10 Teshima M, Iwae S, Hirayama Y, Furukawa T. Nonsteroidal anti-inflammatory drug treatment for desmoid tumor recurrence after surgery. Otolaryngol Head Neck Surg 2012; 147 (05) 978-979
• 11 Skapek SX, Anderson JR, Hill DA. et al. Safety and efficacy of high-dose tamoxifen and sulindac for desmoid tumor in children: results of a Children's Oncology Group (COG) phase II study. Pediatr Blood Cancer 2013; 60 (07) 1108-1112
• 12 Skapek SX, Hawk BJ, Hoffer FA. et al. Combination chemotherapy using vinblastine and methotrexate for the treatment of progressive desmoid tumor in children. J Clin Oncol 1998; 16 (09) 3021-3027
• 13 Gounder MM, Mahoney MR, Van Tine BA. et al. Sorafenib for advanced and refractory desmoid tumors. N Engl J Med 2018; 379 (25) 2417-2428
• 14 Toulmonde M, Pulido M, Ray-Coquard I. et al. Pazopanib or methotrexate-vinblastine combination chemotherapy in adult patients with progressive desmoid tumours (DESMOPAZ): a non-comparative, randomised, open-label, multicentre, phase 2 study. Lancet Oncol 2019; 20 (09) 1263-1272
• 15 Acker JC, Bossen EH, Halperin EC. The management of desmoid tumors. Int J Radiat Oncol Biol Phys 1993; 26 (05) 851-858
• 16 Kurtz JE, Buy X, Deschamps F. et al. CRYODESMO-O1: a prospective, open phase II study of cryoablation in desmoid tumour patients progressing after medical treatment. Eur J Cancer 2021; 143: 78-87
• 17 von Mehren M, Kane JM, Bui MM. et al. NCCN guidelines insights: soft tissue sarcoma, version 1. J Natl Compr Canc Netw 2020; 18 (12) 1604-1612
• 18 Goldberg D, Woodhead G, Hannallah J, Young S. Role of the interventional radiologist in the treatment of desmoid tumors. Life (Basel) 2023; 13 (03) 645-656
• 19 Livraghi T, Festi D, Monti F, Salmi A, Vettori C. US-guided percutaneous alcohol injection of small hepatic and abdominal tumors. Radiology 1986; 161 (02) 309-312
• 20 Lee MJ, Mueller PR, Dawson SL. et al. Percutaneous ethanol injection for the treatment of hepatic tumors: indications, mechanism of action, technique, and efficacy. AJR Am J Roentgenol 1995; 164 (01) 215-220
• 21 Lu DE, Cheng SW, Lin YS. et al. Combination of radiofrequency ablation and percutaneous ethanol injection versus radiofrequency ablation alone for hepatocellular carcinoma: a systematic review and meta-analysis. Ann Hepatol 2022; 27 (05) 100729
• 22 Clark TWI. Percutaneous chemical ablation of desmoid tumors. J Vasc Interv Radiol 2003; 14 (05) 629-634
• 23 Ohnishi K, Yoshioka H, Ito S, Fujiwara K. Randomized controlled trial comparing acetic acid injection and percutaneous ethanol injection for small hepatocellular carcinoma. Hepatology 1998; 27: 67-72
• 24 Haemmerich D. Biophysics of radiofrequency ablation. Crit Rev Biomed Eng 2010; 38 (01) 53-63
• 25 Tsz-Kan T, Man-Kwong C, Shu Shang-Jen J, Ying-Lee L, Wai Man-Wah A, Hon-Shing F. Radiofrequency ablation of recurrent fibromatosis. J Vasc Interv Radiol 2007; 18 (1, Pt 1): 147-150
• 26 Wang L, Xu D, Chen L, Huang P. Percutaneous ultrasound-guided radiofrequency ablation for giant desmoid tumors of the intra-abdominal cavity in a patient with Gardner syndrome. J Cancer Res Ther 2021; 17 (05) 1286-1288
• 27 Cobianchi L, Ravetta V, Viera FT. et al. The challenge of extraabdominal desmoid tumour management in patients with Gardner's syndrome: radiofrequency ablation, a promising option. World J Surg Oncol 2014; 12: 361-363
• 28 Ilaslan H, Schils J, Joyce M, Marks K, Sundaram M. Radiofrequency ablation: another treatment option for local control of desmoid tumors. Skeletal Radiol 2010; 39 (02) 169-173
• 29 Barrow E, Newton K, Rajashanker B, Lee S, Evans DG, Hill J. Successful radiofrequency ablation of an anterior abdominal wall desmoid in familial adenomatous polyposis. Colorectal Dis 2013; 15 (03) e160-e163
• 30 Lubner MG, Brace CL, Hinshaw JL, Lee Jr FT. Microwave tumor ablation: mechanism of action, clinical results, and devices. J Vasc Interv Radiol 2010; 21 (8, Suppl): S192-S203
• 31 Martínez-Martínez A, García-Espinosa J, Láinez Ramos-Bossini AJ, Ruiz Santiago F. Percutaneous microwave ablation of desmoid fibromatosis. Korean J Radiol 2021; 22 (06) 944-950
• 32 Erinjeri JP, Clark TWI. Cryoablation: mechanism of action and devices. J Vasc Interv Radiol 2010; 21 (8, Suppl): S187-S191
• 33 Huang K, Hong R, Luo L. et al. Efficacy and safety of different thermal ablative therapies for desmoid-type fibromatosis: a systematic review and meta-analysis. Quant Imaging Med Surg 2023; 13 (10) 6683-6697
• 34 Johnston EW, Alves A, Messiou C. et al. Percutaneous cryoablation for desmoid fibromatosis: initial experience at a UK centre. Clin Radiol 2022; 77 (10) 784-793
• 35 Colak C, Hull C, Simpfendorfer C, Ilaslan H, Forney M. Extra-abdominal desmoid fibromatosis: cryoablation versus traditional therapies. Clin Imaging 2022; 88: 9-16
• 36 Mandel JE, Kim D, Yarmohammadi H. et al. Percutaneous cryoablation provides disease control for extra-abdominal desmoid-type fibromatosis comparable with surgical resection. Ann Surg Oncol 2022; 29 (01) 640-648
• 37 Quek LHH, Lim MY, Cheo T, Teo HL, Pua U. Percutaneous management of recurrent head and neck cancer: current role and evolving principles in the multidisciplinary setting. Curr Oncol Rep 2021; 23 (05) 52-61
• 38 Morris J, Michalak G, Leng S. et al. Dual-energy CT monitoring of cryoablation zone growth in the spinal column and bony pelvis: a laboratory study. J Vasc Interv Radiol 2019; 30 (09) 1496-1503
• 39 Haar GT, Coussios C. High intensity focused ultrasound: past, present and future. Int J Hyperthermia 2007; 23 (02) 85-87
• 40 Griffin MO, Kulkarni NM, OʼConnor SD, Sudakoff GS, Lea WB, Tutton SM. Magnetic resonance-guided focused ultrasound: a brief review with emphasis on the treatment of extra-abdominal desmoid tumors. Ultrasound Q 2019; 35 (04) 346-354
• 41 Zhong X, Hu X, Zhao P. et al. The efficacy of low-power cumulative high-intensity focused ultrasound treatment for recurrent desmoid tumor. Cancer Med 2022; 11 (10) 2079-2084
• 42 Düx DM, Baal JD, Bitton R. et al. MR-guided focused ultrasound therapy of extra-abdominal desmoid tumors: a multicenter retrospective study of 105 patients. Eur Radiol 2024; 34 (02) 1137-1145
• 43 Lee YC, Lee JW. Innovative treatment for huge nuchal desmoid tumour: a case report with a 2-year follow-up. J Plast Reconstr Aesthet Surg 2010; 63 (08) e622-e626
• 44 Hori A, Murata S, Kono M. et al. [Effect of transarterial chemoembolization for recurrent desmoid tumor - a case report]. Gan To Kagaku Ryoho 2013; 40 (09) 1259-1262
• 45 Elnekave E, Ben Ami E, Shamai S. et al. Selective intra-arterial doxorubicin eluting microsphere embolization for desmoid fibromatosis: a combined prospective and retrospective study. Cancers (Basel) 2022; 14 (20) 5045-5044
• 46 Kim D, Keohan ML, Gounder MM, Crago AM, Erinjeri JP. Transarterial chemoembolization with doxorubicin eluting beads for extra-abdominal desmoid tumors: initial experience. Cardiovasc Intervent Radiol 2022; 45 (08) 1141-1151
• 47 Braschi-Amirfarzan M, Keraliya AR, Krajewski KM. et al. Role of imaging in management of desmoid-type fibromatosis: a primer for radiologists. Radiographics 2016; 36 (03) 767-782
• 48 Páez-Carpio A, Haghanil L, Erinjeri JP. Minimizing cutaneous complications of chemoembolization of extra-abdominal desmoid tumor using tumescent vasoconstriction of skin blood vessels. Cardiovasc Intervent Radiol 2023; 46 (04) 525-527